title: Nickel-regulated heart rate variability: the roles of oxidative stress and inflammation.
abstract: Heart rate variability (HRV) has been reported to be a putative marker of cardiac autonomic imbalance caused by exposure to ambient particulate matter (PM). Our objective in this study was to determine the effects on HRV from exposure to nickel, an important chemical component of ambient PM that results in oxidative stress and inflammation. HRV data were collected for 72 h before lung exposure (baseline) and 72 h after intratracheal exposure (response) to nickel sulphate (NiSO(4); 526 μg) in Wistar Kyoto (WKY) and spontaneously hypertensive (SH) rats. The antioxidant N-acetyl-L-cysteine (NAC) and the anti-inflammatory celecoxib were intraperitoneally injected to examine post-exposure oxidative and inflammatory responses. Self-controlled experiments examined the effects of NiSO(4) exposure on average normal-to-normal intervals (ANN), natural logarithm-transformed standard deviation of the normal-to-normal intervals (LnSDNN) and root mean square of successive differences of adjacent normal-to-normal intervals (LnRMSSD); the resulting data were sequentially analysed using the generalised estimating equation model. HRV effects on NiSO(4)-exposed SH rats were greater than those on NiSO(4)-exposed WKY rats. After adjusted the HRV responses in the WKY rats as control, ANN and LnRMSSD were found to be quadratically increased over 72 h after exposure to NiSO(4). Both NAC and celecoxib mitigated the NiSO(4)-induced alterations in HRV during the exposure period. The results suggest that concurrent Ni-induced oxidative stress and inflammatory responses play important roles in regulating HRV. These findings help bridge the gap between epidemiological and clinical studies on the plausible mechanisms of the cardiovascular consequences induced by chemical components in ambient PM.
authors.affiliation: School of Respiratory Therapy, College of Medicine, Taipei Medical University, and Division of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei, Taiwan. r92841005@ntu.edu.tw
authors.forename: Hsiao-Chi
authors.initials: HC
authors.lastname: Chuang
authors.forename: Tzu-Wei
authors.initials: TW
authors.lastname: Hsueh
authors.forename: Chuen-Chau
authors.initials: CC
authors.lastname: Chang
authors.forename: Jing-Shiang
authors.initials: JS
authors.lastname: Hwang
authors.forename: Kai-Jen
authors.initials: KJ
authors.lastname: Chuang
authors.forename: Yuan-Horng
authors.initials: YH
authors.lastname: Yan
authors.forename: Tsun-Jen
authors.initials: TJ
authors.lastname: Cheng
mesh_terms: D000111:Acetylcysteine / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000975:Antioxidants / Q000494:pharmacology*; D000068579:Celecoxib; D006339:Heart Rate / Q000187:drug effects*; D007249:Inflammation / Q000139:chemically induced*; D007274:Injections, Intraperitoneal; D008297:Male; D008962:Models, Theoretical; D009532:Nickel / Q000633:toxicity*; D018384:Oxidative Stress / Q000187:drug effects*; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D013449:Sulfonamides / Q000494:pharmacology
chemical_list: D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D011720:Pyrazoles; D013449:Sulfonamides; C029938:nickel sulfate; D009532:Nickel; D000068579:Celecoxib; D000111:Acetylcysteine